IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aldebaran Capital, LLC

Q2 2025 Holdings

Filed 2025-08-12 | 34 holdings | $101.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Berkshire Hathaway Inc del(BRK/B)CL B NEW084670702$20.5M42,17220.2%
Microsoft Corp(MSFT)COM594918104$9.5M19,1069.4%
Bunge Limited(BG)COMH11356104$7.9M98,1177.8%
Occidental Pete Corp(OXY)COM674599105$7.2M171,0387.1%
Lilly ELI & Co(LLY)COM532457108$6.1M7,7836.0%
Ishares TR RUS Mdcp VAL(IWS)ETF464287473$5.2M39,4665.1%
Bank America Corp(BAC)COM060505104$5.2M109,6655.1%
Suncor Energy Inc New(SU)COM867224107$4.5M121,1594.5%
Chevron Corp New(CVX)COM166764100$4.0M27,8653.9%
JPMorgan Chase & Co(JPM)COM46625H100$3.5M11,9073.4%
Abrdn Etfs(BCI)BBRG ALL COMD K1003261104$3.1M150,0533.1%
Cato Corp New(CATO)CL A149205106$2.9M1,043,7022.9%
Sirius XM Holdings Inc(SIRI)COMMON STOCK829933100$2.6M112,7942.6%
Freeport-Mcmoran Inc(FCX)CL B35671D857$2.2M50,9032.2%
Enbridge Inc(ENB)COM29250N105$1.9M41,7761.9%
Verizon Communications Inc(VZ)COM92343V104$1.7M40,1031.7%
Berkshire Hathaway Inc del(BRK/A)CL A084670108$1.5M21.4%
Aclaris Therapeutics Inc(ACRS)COM00461U105$1.4M993,6981.4%
Amylyx Pharmaceuticals Inc(AMLX)COM03237H101$1.4M217,8271.4%
Richardson Electrs LTD(RELL)COM763165107$1.4M144,1351.4%
Patrick Inds Inc(PATK)COM703343103$1.3M14,2341.3%
Century Alum Co(CENX)COM156431108$1.1M61,1851.1%
Essa Pharma Inc(EPIEUR)COM NEW29668H708$984.2K578,9391.0%
Tectonic Therapeutic Inc(TECX)COM878972108$799.9K40,2580.8%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$546.0K515,1280.5%
Teck Resources LTD(TECK)COM878742204$513.5K12,7160.5%
An2 Thereapeutics IncCOM373261056$426.9K402,7540.4%
Duke Energy Corp NewCOM NEW26441C105$424.8K3,6000.4%
Merchants Bancorp IND(MBIN)COM58844R108$334.8K10,1250.3%
Ikena Oncology IncCOM45175G108$324.4K242,1160.3%
General Electric CoCOM369604103$323.3K1,2560.3%
Ford MTR Co del(F)COM345370860$305.4K28,1500.3%
Procter and Gamble Co(PG)COM742718109$200.8K1,2600.2%
Onkure Therapeutics Inc(OKUR)COM CL A68277Q105$105.6K44,1730.1%